XML 133 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Business Segments and Geographic Information
 12 Months Ended
Sep. 28, 2019
Segment Reporting [Abstract]  
Business Segments and Geographic Information Business Segments and Geographic Information
The Company reports segment information in accordance with ASC 280, Segment Reporting. Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company’s chief operating decision maker is its chief executive officer, and the Company’s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. The Company has five reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration
expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.
Identifiable assets for the five reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its five reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues. Segment information for fiscal 2019, 2018, and 2017 was as follows:
 
 
Years ended
 
 
September 28,
2019
 
September 29,
2018
 
September 30,
2017
Total revenues:
 
 
 
 
 
 
Diagnostics
 
$
1,205.5

 
$
1,147.4

 
$
1,197.1

Breast Health
 
1,314.2

 
1,218.2

 
1,138.3

Medical Aesthetics
 
315.6

 
339.1

 
207.5

GYN Surgical
 
437.2

 
422.0

 
427.1

Skeletal Health
 
94.8

 
91.2

 
88.8

 

$
3,367.3


$
3,217.9

 
$
3,058.8

Operating (loss) income:
 
 
 
 
 
 
Diagnostics
 
$
163.1

 
$
145.5

 
$
1,054.2

Breast Health
 
399.3

 
399.7

 
373.4

Medical Aesthetics
 
(781.2
)
 
(844.7
)
 
(115.9
)
GYN Surgical
 
99.2

 
58.3

 
65.0

Skeletal Health
 
(4.2
)
 
3.3

 
(6.5
)
 
 
$
(123.8
)
 
$
(237.9
)
 
$
1,370.2

Depreciation and amortization:
 
 
 
 
 
 
Diagnostics
 
$
246.6

 
$
257.3

 
$
278.9

Breast Health
 
36.8

 
22.7

 
19.7

Medical Aesthetics
 
91.4

 
108.1

 
54.2

GYN Surgical
 
87.7

 
91.6

 
95.7

Skeletal Health
 
0.6

 
0.6

 
0.7

 

$
463.1


$
480.3

 
$
449.2

Capital expenditures:
 
 
 
 
 
 
Diagnostics
 
$
59.2

 
$
57.7

 
$
50.9

Breast Health
 
18.3

 
14.8

 
12.0

Medical Aesthetics
 
7.0

 
9.4

 
7.3

GYN Surgical
 
15.7

 
13.1

 
15.2

Skeletal Health
 
1.2

 
3.3

 
1.2

Corporate
 
7.7

 
7.3

 
21.0

 

$
109.1


$
105.6

 
$
107.6

 
 
 
September 28,
2019
 
September 29,
2018
 
September 30,
2017
Identifiable assets:
 
 
 
 
 
 
Diagnostics
 
$
2,276.6

 
$
2,442.9

 
$
2,621.6

Breast Health
 
1,127.8

 
972.4

 
824.0

Medical Aesthetics
 
159.3

 
913.3

 
1,751.2

GYN Surgical
 
1,328.6

 
1,414.9

 
1,494.6

Skeletal Health
 
27.3

 
30.3

 
25.5

Corporate
 
1,522.5

 
1,457.1

 
1,262.7

 
 
$
6,442.1

 
$
7,230.9

 
$
7,979.6


The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “Rest of world” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 
 
Years ended
 
 
September 28,
2019
 
September 29,
2018
 
September 30,
2017
United States
 
75.3
%
 
75.1
%
 
77.6
%
Europe
 
11.8
%
 
11.7
%
 
10.0
%
Asia-Pacific
 
8.5
%
 
8.6
%
 
8.1
%
Rest of world
 
4.4
%
 
4.6
%
 
4.3
%
 
 
100.0
%
 
100.0
%
 
100.0
%


The Company’s property, plant and equipment, net are geographically located as follows:
 
 
September 28, 2019
 
September 29, 2018
 
September 30, 2017
United States
 
$
355.5

 
$
366.5

 
$
368.1

Costa Rica
 
33.0

 
30.9

 
30.1

Europe
 
64.4

 
62.0

 
57.1

Rest of world
 
18.0

 
18.8

 
17.5

 
 
$
470.9

 
$
478.2

 
$
472.8